FDA Reviews Samsung Bioepis’ Bevacizumab

Avastin Rival Will Be Sold Through Merck, Sharp & Dohme

 
• By David Wallace
Accepted_Stamp
Samsung Bioepis’ Bevacizumab Filing Has Been Accepted By The FDA • Source: Shutterstock

More from Biosimilars

More from Products